Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

SHP 4,946.90 +130.90 (2.72%)
price chart
Why I'm Selling GlaxoSmithKline plc And Buying Shire PLC
Finding a company that has the perfect blend of both growth and income is a difficult game to play. However, it looks as if Shire (LSE: SHP) could be the perfect pick. Up until now, my pharmaceutical sector favourite has been GlaxoSmithKline (LSE: GSK ...
Shire plc (SHPG) Receives FDA Fast-Track Designation for SHP609
Shire plc (NASDAQ: SHPG) announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP609 (idursulfase-IT; also known as HGT-2310) for the treatment of neurocognitive decline associated with Hunter ...
Shire plc (SHPG) Comments on FDA Approval of NATPARA (NPSP)
Shire plc (Nasdaq: SHPG) notes the announcement by NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) that the U.S. Food and Drug Administration (FDA) has approved NATPARA (parathyroid hormone) as an adjunct to calcium and vitamin D to control ...
FDA approves NPS drug, in move validating Shire takeover deal  Reuters
NPS Pharmaceuticals, Inc. (NPSP) Wins FDA Approval For Natpara, Validating ...  Bidness ETC
Why I Would Buy International Consolidated Airlines Grp And Shire PLC But Sell ...
Phamaceuticals giant Shire (LSE: SHP) has received a shot in the arm in Monday trade and was last up 0.6% on the day. The business has been boosted by news that the US Food and Drug Administration (FDA) had approved NPS Phamaceuticals' Natpara, ...
Analyst Upgrades: Shire plc, Garmin Ltd., and Visa Inc.
Analysts are weighing in today on biopharmaceutical issue Shire PLC (ADR) (NASDAQ:SHPG), GPS maker Garmin Ltd. (NASDAQ:GRMN), and credit card concern Visa Inc (NYSE:V).
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
Back in February last year I penned an article titled David & Goliath: AstraZeneca versus Hikma Pharmaceuticals, which compared the prospects of the two firms and suggested that looking down the food chain in the pharmaceutical sector could produce an ...
How Will GlaxoSmithKline plc, AstraZeneca plc And Shire PLC Fare During 2015?
You don't need me to tell you that safety-conscious, conservative investors with a penchant for defensive shares endured something of a sustained pummelling during 2014 from that traditional safe haven, the supermarket sector.
Related articles »  
Why I Think Shire plc Will Outperform AstraZeneca plc And GlaxoSmithKline plc ...
You probably know everything about GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) by now: a bribery scandal in China, falling earnings and a patent cliff have all weighed on its equity valuation in recent times.
AstraZeneca plc, GlaxoSmithKline plc And Shire PLC Are Set For A Decade Of ...
The UK three main pharmaceutical companies, AstraZeneca (LSE: AZN), GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are all at key stages in the development of their treatment pipelines.
Shire PLC Sees Unusually-High Trading Volume After Analyst Upgrade (SHPG)
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.
Shire PLC Given New $248.00 Price Target at RBC Capital (SHPG)  Ticker Report
Shire (SHPG) Strong In Pre-Market Trading  TheStreet.com